Edition:
United States

Accelerate Diagnostics Inc (AXDX.OQ)

AXDX.OQ on NASDAQ Stock Exchange Capital Market

20.95USD
13 Jul 2018
Change (% chg)

$-0.50 (-2.33%)
Prev Close
$21.45
Open
$21.35
Day's High
$21.45
Day's Low
$20.85
Volume
42,661
Avg. Vol
57,526
52-wk High
$30.30
52-wk Low
$16.85

Latest Key Developments (Source: Significant Developments)

Accelerate Diagnostics announces pricing of $150 mln notes offering
Friday, 23 Mar 2018 02:15am EDT 

March 23 (Reuters) - Accelerate Diagnostics Inc ::ACCELERATE DIAGNOSTICS, INC. ANNOUNCES PRICING OF $150 MILLION CONVERTIBLE NOTES OFFERING.‍PRICING OF $150.0 MILLION AGGREGATE PRINCIPAL AMOUNT OF 2.50% CONVERTIBLE SENIOR NOTES DUE 2023​.ACCELERATE DIAGNOSTICS- ‍AN ENTITY AFFILIATED WITH ONE OF ACCELERATE DIAGNOSTICS'S DIRECTORS HAS AGREED TO PURCHASE AN AGGREGATE OF $30 MILLION OF NOTES​.‍SALE OF NOTES TO INITIAL PURCHASERS EXPECTED TO RESULT IN ABOUT $145.6 MILLION IN NET PROCEEDS TO ACCELERATE DIAGNOSTICS​.  Full Article

Accelerate Diagnostics Announces $150 Mln Convertible Notes Offering
Thursday, 22 Mar 2018 07:08am EDT 

March 22 (Reuters) - Accelerate Diagnostics Inc ::ACCELERATE DIAGNOSTICS INC. ANNOUNCES $150 MILLION CONVERTIBLE NOTES OFFERING.ACCELERATE DIAGNOSTICS - INTENTION TO OFFER $150.0 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2023.ACCELERATE DIAGNOSTICS INC - ‍EXPECTS TO USE PART OF PROCEEDS OF OFFERING TO PAY PREPAYMENT AMOUNT OF THE PREPAID FORWARD.ACCELERATE DIAGNOSTICS - EXPECTS TO ENTER PRIVATELY NEGOTIATED PREPAID FORWARD WITH AFFILIATE OF ONE OF INITIAL PURCHASERS OF NOTES.ACCELERATE DIAGNOSTICS INC - ‍WILL PURCHASE ITS COMMON STOCK FOR SETTLEMENT ON OR AROUND MARCH 15, 2023​.  Full Article

Accelerate Diagnostics Qtrly Net Loss $0.27 Per Share
Thursday, 15 Feb 2018 04:05pm EST 

Feb 15 (Reuters) - Accelerate Diagnostics Inc ::ACCELERATE DIAGNOSTICS REPORTS Q4 AND FULL-YEAR FINANCIAL RESULTS FOR 2017.SEES FY 2018 REVENUE $21 MILLION TO $30 MILLION.Q4 SALES $2.1 MILLION.QTRLY NET LOSS $0.27 PER SHARE.Q4 EARNINGS PER SHARE VIEW $-0.32, REVENUE VIEW $2.4 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Accelerate Diagnostics reports Q3 loss per share $0.31
Thursday, 2 Nov 2017 04:01pm EDT 

Nov 2 (Reuters) - Accelerate Diagnostics Inc :Accelerate Diagnostics Inc reports q3 2017 financial results.Q3 loss per share $0.31.Q3 earnings per share view $-0.32 -- Thomson Reuters I/B/E/S.  Full Article

Plaintiffs dismiss class action appeal against Accelerate Diagnostics
Wednesday, 13 Sep 2017 01:05pm EDT 

Sept 13 (Reuters) - Accelerate Diagnostics Inc :Plaintiffs dismiss class action appeal against Accelerate Diagnostics.Says ‍court signed order dismissing plaintiffs' appeal of class action lawsuit filed against accelerate,certain of co's executives​.Says ‍shortly before appeal was scheduled to be argued, plaintiffs/appellants voluntarily requested that case be dismissed​.  Full Article

Accelerate Diagnostics reports Q2 loss per share $0.31
Thursday, 3 Aug 2017 04:00pm EDT 

Aug 3 (Reuters) - Accelerate Diagnostics Inc :Accelerate Diagnostics reports Q2 2017 financial results, doubles revenue generating placements.Q2 loss per share $0.31.Q2 earnings per share view $-0.30 -- Thomson Reuters I/B/E/S.  Full Article

Accelerate Diagnostics prices upsized offering of 2.75 mln shares at $28.85 per share
Tuesday, 9 May 2017 10:00pm EDT 

May 9 (Reuters) - Accelerate Diagnostics Inc :Accelerate diagnostics announces pricing of upsized public offering of common stock.Public offering of 2.75 million shares of its common stock upsized from original share offering of 2.5 million shares.Accelerate diagnostics -offering upsized from original share offering of 2.5 million shares of common stock, at price to public of $28.85 per share.  Full Article

Accelerate Diagnostics announces proposed public offering of common stock
Monday, 8 May 2017 04:15pm EDT 

May 8 (Reuters) - Accelerate Diagnostics Inc :Accelerate Diagnostics announces proposed public offering of common stock.Accelerate Diagnostics Inc says has commenced an underwritten public offering of 2.5 million shares of its common stock.  Full Article

Accelerate Diagnostics reports Q1 sales $530,000
Wednesday, 3 May 2017 04:05pm EDT 

May 3 (Reuters) - Accelerate Diagnostics Inc :Accelerate Diagnostics reports 191 instruments under contract and 3x revenue growth for first quarter 2017.Q1 sales $530,000 versus $163,000.Q1 revenue view $1.2 million -- Thomson Reuters I/B/E/S.Q1 loss per share $0.27.Q1 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S.  Full Article

Accelerate Diagnostics reports Q1 sales $530,000
Wednesday, 3 May 2017 04:05pm EDT 

May 3 (Reuters) - Accelerate Diagnostics Inc :Accelerate Diagnostics reports 191 instruments under contract and 3X revenue growth for first quarter 2017.Q1 sales $530,000 versus $163,000.Q1 loss per share $0.27.Q1 revenue view $1.2 million -- Thomson Reuters I/B/E/S.Q1 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Accelerate Diagnostics Q1 Loss Per Share $0.37

* Q1 EARNINGS PER SHARE VIEW $-0.32 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: